Ultraviolet light is getting attention in fight against coronavirus

Research already shows that germicidal UV can effectively inactivate airborne microbes that transmit measles, tuberculosis and SARS-CoV-1, a close relative of the novel coronavirus. Now, with concern mounting that the coronavirus that causes COVID-19 may be easily transmitted through microscopic floating particles known as aerosols, some researchers and physicians hope the technology can be recruited yet again to help disinfect high-risk indoor settings.

Regeneron Starts Phase 3 Trial For Coronavirus Antibody Cocktail

Regeneron Pharmaceuticals has started late-stage clinical trials evaluating REGN-COV2, its investigational double antibody cocktail for the treatment and prevention of COVID-19. A Phase 3 trial will evaluate REGN-COV2's ability to prevent infection among uninfected people who have had close exposure to a COVID-19 patient.

Do Lysol, Microban 24 kill coronavirus? Cleaning products to look for

In March, the EPA released a lengthy list of household cleaners that were expected to be effective against coronavirus because they have been tested and proven to work against similar viruses. The list includes products like Clorox disinfecting wipes and spray and Microban 24 products. Two Lysol products were lab tested by the EPA directly against COVID-19.

The next COVID-19 challenge: Convincing people to get flu shots

Public health officials, doctors and pharmacists who have struggled for decades to convince Americans to get the flu shot are warning it is now more important than ever to get vaccinated as the U.S. faces a potential second wave of COVID-19 in the fall.

Coronavirus: Immunity passports ‘could increase virus spread’

WHO says governments should not issue so-called immunity passports" as a way of easing lockdowns. No evidence people who develop antibodies after recovering are protected against a second infection. WHO warns that such move could actually increase the spread of the virus transmission. People who assumed they were immune could stop taking precautions.

The US already has the technology to test millions of people a day

There is widespread agreement that the only way to safely reopen the economy is through a massive increase in testing. Tests for mass screening may have different requirements and characteristics from the tests run in clinical labs today that are approved by the Food and Drug Administration. So what might a solution look like?